← Back to Influence Map
Advisory Committee; Arthritis Advisory Committee; Termination; Removal From List of Standing Committees
introducedrepealedThe Food and Drug Administration (FDA or the Agency) is announcing the termination of the Arthritis Advisory Committee (Committee). Due to that termination, this final rule removes the Committee from the Agency's list of standing advisory committees in 21 CFR 14.100.
No lobbying positions or financial data recorded for this regulation yet.
Public comment data and advocacy positions are added as they become available.